Page 18 - MEMOCiberes014-ENG

INTRODUCTION
Corporate Research Programmes (CRPs) are the corporate scientific work tool of CIBERES . A CRP is defined by a Strategic Project (SP) for research addressing a relevant health problem in the scope of respiratory diseases in a cooperative and comprehensive manner .
Strategic Projects (SPs) have been structured as work packets following the format of projects funded by the European Commission in the different framework research programmes and are clearly intended for transferring and translating results, therefore seeking the public investment to be returned to society as a whole .
As in previous years, for the 2014 fiscal year the CIBERES Steering Committee approved a budget item for each CRP . This budget item was managed by the Scientific Committee of each programme which has established the scientific priorities of each . The amount assigned to each CRP was variable and was calculated based on the interest expressed by CIBERES researchers in participating in each of said programmes and on the external evaluations received:
To assure the correct development of the SPs, CIBERES Scientific Management decided to subject the SPs to a new external follow-up evaluation at the beginning of 2014 . The follow-up was performed in two phases . In a first phase, coordinators and managers of the job packets for each project were asked to complete an ad hoc form in which they were asked to provide comprehensive information about the development of the project and about the results obtained . In a second phase, the coordinators were asked to perform a presentation of the evolution of the project in its first 12 months of execution before a panel of 3 experts of recognised prestige in the field of biomedical research who had previously reviewed the forms completed in the preceding phase .
The experts making up the panel were:
Dr. Bartolome Celli. President of the CIBERES External Scientific Committee Dr. Joaquín Arenas. Director of the Instituto de Investigación of Hospital 12 de Octubre . Dr. Francisco Pozo. Consultant Researcher . Instituto de Investigación of Hospital 12 de Octubre .
PCI
Budget 2014
Asma Grave
88 .541,49€
Fibrosis Pulmonar
34 .339,31€
EPOC
163 .749,97€
Cáncer
97 .559,60€
Lesión Pulmonar Aguda
251 .275,66€
Síndrome de Apnea del Sueño
175 .866,89€
Neumonía
254 .656,02€
Tuberculosis
89 .832,71€
Nuevas Dianas Terapeúticas
247 .178,32€
TOTAL
1.402.999,97€
18 CIBERES » Annual report 2014